In Silico Strategies in Tuberculosis Drug Discovery

Tuberculosis (TB) remains a serious threat to global public health, responsible for an estimated 1.5 million mortalities in 2018. While there are available therapeutics for this infection, slow-acting drugs, poor patient compliance, drug toxicity, and drug resistance require the discovery of novel T...

Descripción completa

Detalles Bibliográficos
Autores principales: Macalino, Stephani Joy Y., Billones, Junie B., Organo, Voltaire G., Carrillo, Maria Constancia O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037728/
https://www.ncbi.nlm.nih.gov/pubmed/32033144
http://dx.doi.org/10.3390/molecules25030665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037728/
https://www.ncbi.nlm.nih.gov/pubmed/32033144
http://dx.doi.org/10.3390/molecules25030665

Ejemplares similares